Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry. (17/23)

 (+info)

A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome. (18/23)

 (+info)

NCX is an important determinant for premature ventricular activity in a drug-induced model of Andersen-Tawil syndrome. (19/23)

 (+info)

Golgi export of the Kir2.1 channel is driven by a trafficking signal located within its tertiary structure. (20/23)

 (+info)

Altered stress stimulation of inward rectifier potassium channels in Andersen-Tawil syndrome. (21/23)

 (+info)

Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome. (22/23)

 (+info)

Phenotype variability in patients carrying KCNJ2 mutations. (23/23)

 (+info)